Shots: MHLW has granted EUA for Vaxzevria (ChAdOx1-S [Recombinant]) for active immunization of individuals aged ≥18yrs. to prevent COVID-19. The EUA is based on P-III data from the Oxford University-led […]readmore
Tags : Emergency Use
Shots: MHLW has granted special approval under article 14-3 of the PMDA for emergency use of Moderna’s mRNA COVID-19 vaccine based on Takeda’s P-I/II immunogenicity and safety clinical trial The […]readmore
Shots: The US FDA has issued the EUA to the hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and utilized to treat patients with […]readmore